Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains

Antimicrob Agents Chemother. 2009 Jun;53(6):2636-7. doi: 10.1128/AAC.01415-08. Epub 2009 Mar 16.

Abstract

We used a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains to study (i) regulation of mprF-mediated phosphatidylglycerol lysinylation in the contexts of in vitro daptomycin (DAP) nonsuceptibility and (ii) the role of mprF mutation in endovascular virulence. We observed a correlation between increased expression of a mutant mprF gene and reduced in vitro DAP susceptibility. There were no detectable fitness differences between strains in experimental infective endocarditis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoacyltransferases / genetics*
  • Aminoacyltransferases / physiology
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / physiology
  • Daptomycin / pharmacology*
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Mutation
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Aminoacyltransferases
  • mprF protein, Staphylococcus aureus
  • Daptomycin